Skip to main content
OpenTrials

Clinical trial condition

Stage 4S Neuroblastoma

Explore clinical trials studying Stage 4S Neuroblastoma. Study availability and eligibility vary by location and protocol.

12 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage 4S Neuroblastoma trial results

Completed

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

NCT00904241

Conditions
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
View all 259 locations
View Trial Details
Completed

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

NCT00026312

Conditions
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neoplasms, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 197 locations
View Trial Details
Completed

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

NCT01175356

Conditions
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 25 locations
View Trial Details
Completed

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

NCT01798004

Conditions
Ganglioneuroblastoma, Neoplasms, Neoplasms by Histologic Type, +15 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 123 locations
View Trial Details
Completed

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma

NCT00033293

Conditions
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neoplasms, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 104 locations
View Trial Details
Completed

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

NCT00567567

Conditions
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neoplasms, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 190 locations
View Trial Details
Completed

Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma

NCT01208454

Conditions
Localized Unresectable Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 13 locations
View Trial Details

Related conditions